MagForce AG buy DerAlmanach100000
Start price
11.02.25
/
100%
€0.001
Target price
25.06.27
€0.005
Performance (%)
900.00%
End price
27.03.25
€0.005
Summary
This prediction ended on 27.03.25 with a price of €0.005. With a performance of 900.00% the BUY prediction by DerAlmanach100000 was a big success. DerAlmanach100000 has 100% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MagForce AG | -25.000% | -25.000% | -62.500% |
| iShares Core DAX® | 0,27 % | 2,50 % | 3,33 % |
| iShares Nasdaq 100 | 1,88 % | 3,49 % | 35,66 % |
| iShares Nikkei 225® | 3,58 % | 8,13 % | 56,65 % |
| iShares S&P 500 | 0,15 % | 1,92 % | 24,11 % |
According to DerAlmanach100000 what are the pros and cons of MagForce AG for the foreseeable future?
Pros
Cons
Comments by DerAlmanach100000 for this prediction
In the thread Magforce AG diskutieren
Kommt noch.....
Kursziel geändert auf 0,005
Stopped prediction by DerAlmanach100000 for MagForce AG
MagForce AG
Start price
Target price
Perf. (%)
€0.003
10.02.26
10.02.26
€0.14
-
11.02.26
11.02.26
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
MagForce AG
Start price
Target price
Perf. (%)
€0.005
04.07.25
04.07.25
€0.050
21.01.29
21.01.29
20.00%
10.02.26
10.02.26
Undervalued
Strong uniques
Could be very worthwhile Investment >20% year
Very capable Management
MagForce AG
Start price
Target price
Perf. (%)
€0.006
17.05.25
17.05.25
-
17.05.28
17.05.28
8.33%
04.06.25
04.06.25
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
MagForce AG
Start price
Target price
Perf. (%)
€0.005
27.03.25
27.03.25
€0.050
27.03.27
27.03.27
20.00%
15.05.25
15.05.25
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
MagForce AG
Start price
Target price
Perf. (%)
€0.001
20.12.24
20.12.24
€0.000
24.12.27
24.12.27
0.00%
11.02.25
11.02.25
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued


